# OnCo record elinzanetant (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/elinzanetant/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "elinzanetant" ;
  schema:name "Elinzanetant"@en ;
  schema:alternateName "elinzanetant"@en, "Lynkuet"@en, "Lynkuet" ;
  schema:description "Lynkuet is a once-a-day capsule for moderate to severe hot flushes and night sweats. In Europe it is approved both for the menopause and for hot flushes caused by the hormone-blocking tablets taken after breast cancer treatment."@en ;
  schema:url <https://onco.cc/drugs/elinzanetant/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/lynkuet> ;
  onco:status "approved" ;
  onco:tag "universe-gap", "ema-register", "supportive" ;
  onco:modality "Small-molecule neurokinin receptor antagonist (oral capsule)" ;
  onco:approval "EU 2025: Moderate to severe vasomotor symptoms, including those caused by adjuvant endocrine therapy for breast cancer (EPAR overview)" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/>, <https://onco.cc/technologies/menopause-after-cancer-treatment/> ;
  onco:companies <https://onco.cc/companies/bayer/> ;
  onco:trials <https://onco.cc/trials/nct05587296/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct05587296-n-engl-j-med-2025/> .